• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Patient Groups Raise a Voice Against Drug Costs in Europe

Article

Two organizations representing patients have demanded a common system of price-fixing for new drugs in Europe.

Tired of the continuous debate over the increasingly high cost of medications, 2 organizations representing patients have demanded a common system of price-fixing for new drugs in Europe. The 2 organizations, the European Patients Forum and the European Organisation for Rare Diseases, have called for a common payment formula for all European nations, rather than have each nation develop it's own nationalized payment and reimbursement scheme. The thought behind the demand is that the united front presented by multiple nations would have a better bargaining power, which would reduce the drug developer's profits.

The groups want a radical new system to ensure patients have access to new medicines without compromising on the sustainability of healthcare systems.

Complete article on Politico: http://politi.co/1IW7H2F

Related Videos
David Andorsky, MD, Rocky Mountain Cancer Center
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology
Video 7 - "Future Opportunities in Genitourinary Cancers"
Video 6 - "LITESPARK-003 Trial Insights: Updates from ESMO 2023"
Video 5 - "Key Highlights from EV-302 Study at ESMO 2023"
Siamak Daneshmand, MD, discusses the results of SunRISe-1 study of TAR-200, an intravesical drug delivery system, in patients with BCG-unresponsive HR NMIBC from ESMO 2023.
Andrew Srisuwananukorn, MD
Dr Jennifer Brown
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.